SC Deorukhkar, S Saini… - … perspectives on infectious …, 2014 - Wiley Online Library
The very nature of infectious diseases has undergone profound changes in the past few decades. Fungi once considered as nonpathogenic or less virulent are now recognized as a …
MC Furlaneto, HP Góes, HF Perini, RC Dos Santos… - Folia microbiologica, 2018 - Springer
Hemolytic factor production by pathogenic Candida species is considered an important attribute in promoting survival within the mammal host through the ability to assimilate iron …
M Mroczyńska, A Brillowska-Dąbrowska - Pathogens, 2021 - mdpi.com
The factors enabling Candida spp. infections are secretion of hydrolytic enzymes, adherence to surfaces, biofilm formation or morphological transition, and fitness attributes …
S Neji, I Hadrich, H Trabelsi, S Abbes… - Journal of biomedical …, 2017 - Springer
Background The aim of this study was to determine the biofilm formation, the extracellular enzymatic activities of 182 clinical isolates of the Candida parapsilosis complex. Methods …
Candida species are the commensal organisms of human and animal mucosa that cause a wide range of debilitating diseases in immunocompromised patients and other susceptible …
F Mohammadi, Z Ghasemi, B Familsatarian… - Revista da Sociedade …, 2020 - SciELO Brasil
INTRODUCTION: The aim of this study was to evaluate some virulence factors in Candida albicans isolates from patients with onychomycosis and determine the correlation between …
Candida auris, first described in 2009, is an opportunistic pathogenic yeast that causes nosocomial outbreaks around the world, with high mortality rates associated with therapeutic …
C Nanoukon, X Argemi, F Sogbo, J Orekan… - International Journal of …, 2017 - Elsevier
Abstract In West Africa, very little consideration has been given to coagulase negative Staphylococci (CNS). Herein, we describe the features contributing to the pathogenicity of …
Objective Candida species are the normal inhabitants of the skin and mucosa that cause a wide range of debilitating diseases in immunocompromised patients and other susceptible …